Enanta Pharmaceuticals, Inc. · NASDAQ:ENTA

Dapice Joshua J. reported a 9.80% stake in Enanta Pharmaceuticals, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 5, 2026

Dapice Joshua J. reported a 9.80% stake in Enanta Pharmaceuticals, Inc., 2,816,862 shares, as a passive investor on Dec 31, 2025. Filed Feb 5, 2026 (Schedule 13G/A).

Stake
9.80%
Shares
2,816,862
Intent
Passive
What changed
Stake changed
Filed together
29 holders

The filing in full

HolderStakeShares
Farallon Capital Partners, L.P.1.80%531,119
Farallon Capital Institutional Partners, L.P.2.10%595,851
Farallon Capital Institutional Partners II, L.P.0.50%150,355
Farallon Capital Institutional Partners III, L.P.0.30%84,528
Four Crossings Institutional Partners V, L.P.0.40%108,002
Farallon Capital Offshore Investors II, L.P.3.80%1,110,733
Farallon Capital (AM) Investors, L.P.0.20%60,191
Farallon Capital F5 Master I, L.P.0.60%176,083
Farallon Partners, L.L.C.9.10%2,640,779
Farallon Institutional (GP) V, L.L.C.0.40%108,002
Farallon F5 (GP), L.L.C.0.60%176,083
Dapice Joshua J.9.80%2,816,862
Dreyfuss, Philip D.9.80%2,816,862
Dunn Hannah E.9.80%2,816,862
Fried, Richard B0%0
Gehani, Varun N.9.80%2,816,862
Giauque, Nicolas9.80%2,816,862
Husen, Avner A.9.80%2,816,862
Kim, David T.9.80%2,816,862
Linn, Michael G.9.80%2,816,862
Luo Patrick (Cheng)9.80%2,816,862
Patel, Rajiv A.0%0
Roberts, Jr., Thomas G.9.80%2,816,862
Saito Edric C.9.80%2,816,862
Seybold, William0%0
Short Daniel S.9.80%2,816,862
Spokes, Andrew J. M.9.80%2,816,862
Warren, John R.9.80%2,816,862
Wehrly, Mark C.9.80%2,816,862

Source

View original at SEC

Related